James S. Cochran, MDOctober 20, 2020

FDA 483 - James S. Cochran, MD - October 20, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore James S. Cochran, MD

Record Details

James S. Cochran, MD, a clinical investigator in Dallas, TX, was inspected regarding a clinical study. The inspection revealed that the investigation was not conducted according to the signed statement of investigator and investigational plan. This included missed and late collections of urine cytology and missed cystoscopies for study subjects, indicating significant deviations from protocol requirements.

Company: James S. Cochran, MD
Inspection Date: October 20, 2020
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West III
Person: Joanne M. Schlossin

Open in Dashboard

ID · bb025575-bdfc-476e-8195-945efdc4b1b4